2116 completed, 697 recruiting, 648 terminated, 626 unknown. 1799 Phase 2, 1515 Phase 1, 623 Not applicable, 428 Phase 3, 72 Phase 4.
Follow this condition Literature Review of Neoplastic Processes trials Research Report on Neoplastic Processes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma 9-ING-41, Carboplatin - Salivary Gland Carcinoma, Adenoid Cystic Carcinoma | Phase 2 | Withdrawn | Actuate Therapeutics Inc. | 2030-12-18 | 2022-02-22 | |
| A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy 177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended phase 2 regime - Cancer, Prostate Cancer | Phase 1 / Phase 2 | Not yet recruiting | CHU de Quebec-Universite Laval | 500 | 2028-03-01 | 2025-03-30 |
| Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment Options Liver transplantation - Colorectal Neoplasms, Liver Neoplasms | Not applicable | Not yet recruiting | Charite University, Berlin, Germany | 260 | 2027-04-01 | 2026-09-10 |
| High Dose Radiotherapy for Palliation (Hi-D) Palliative Radiotherapy - Metastases, Palliative Radiotherapy | Not applicable | Not yet recruiting | British Columbia Cancer Agency | 21 | 2027-03-01 | 2026-08-12 |
| Improving Processes of Cancer Care Delivery at a Comprehensive Cancer Center Discussion, Electronic Health Record Review, Questionnaire Administration - Metastatic Malignant Solid Neoplasm | Not yet recruiting | M.D. Anderson Cancer Center | 200 | 2027-01-30 | 2026-09-11 | |
| Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor avutometinib capsule + defactinib tablet - MPNST (Malignant Peripheral Nerve Sheath Tumor) | Phase 2 | Not yet recruiting | Girish Dhall, MD | 23 | 2027-01-01 | 2026-08-04 |
| Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases Trastuzumab Deruxtecan, Stereotactic Radiosurgery - Breast Cancer, HER2-positive Breast Cancer | Phase 1 | Not yet recruiting | Baptist Health South Florida | 20 | 2027-01-01 | 2026-10-01 |
| Oral Tetrahydrouridine-Decitabine in Patients With Advanced Myeloproliferative Neoplasms Oral THU-decitabine - Myelofibrosis, MPN - Accelerated or Blast Phase | Phase 2 | Not yet recruiting | John Mascarenhas | 20 | 2027-01-01 | 2026-10-14 |
| Predicting Severe Cardiac Arrhythmias in the Perioperative Period Using AI-ECG digital single-channel ECG recording - Atrial Fibrillation, Atrioventricular Block, Second and Third Degree | Not yet recruiting | I.M. Sechenov First Moscow State Medical University | 300 | 2026-12-31 | 2026-02-10 | |
| Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors ISM5939, Cisplatin, Docetaxel - Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | Not yet recruiting | InSilico Medicine Hong Kong Limited | 159 | 2026-12-30 | 2026-07-23 |
| Adoption of Audio Recording in the Outpatient Supportive Care Center Communication Intervention, Questionnaire Administration - Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm | Not yet recruiting | M.D. Anderson Cancer Center | 200 | 2026-12-30 | 2026-07-16 | |
| Labyrinthin Vaccination in Veterans With Lung Adenocarcinoma LabVax 3(22)-23 and GM-CSF (adjuvant) in combination with pembrolizumab - Type and Grade of Toxicities, Demographic and Background Characteristics, Advanced, Metastatic, Recurrent Adenocarcinoma and Malignant Solid Neoplasm | Phase 2 | Not yet recruiting | VA Office of Research and Development | 30 | 2026-12-01 | 2026-10-06 |
| Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer Epigenetic Assay - Breast Cancer (Locally Advanced or Metastatic), Healthy Volunteers (HV) | Not yet recruiting | University of Maryland, Baltimore | 450 | 2026-12-01 | 2026-09-10 | |
| A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation LG00313112 - Ovarian Cancer, Small Cell Lung Cancer | Phase 1 / Phase 2 | Not yet recruiting | LG Chem | 250 | 2026-12-01 | 2026-08-07 |
| A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant Maintenance Therapy, No intervention - Myeloid Disorders, Myelodysplastic Syndromes | Phase 2 | Not yet recruiting | Medical College of Wisconsin | 450 | 2026-12-01 | 2026-10-13 |
| Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Tumors, ONE SHOT Trial Computed Tomography, Magnetic Resonance Imaging, MRI-guided Stereotactic Body Radiation Therapy - Metastatic Malignant Solid Neoplasm | Not applicable | Not yet recruiting | Jonsson Comprehensive Cancer Center | 25 | 2026-12-01 | 2026-08-24 |
| Plant-Based Nutrition for Breast or Endometrial Cancer Control, Whole Food, Plant-Based Diet with Behavioral Education and Support - Breast Cancer Metastatic, Endometrial Cancer Stage IV | Not applicable | Not yet recruiting | University of Rochester | 60 | 2026-12-01 | 2026-04-08 |
| Real-world Trial of Individualized Precision Oncology Molecularly matched therapy, Standard of care - Metastatic Cancer, Unresectable Carcinoma | Phase 2 | Not yet recruiting | University of California, San Diego | 280 | 2026-12-01 | 2026-09-03 |
| Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer modified FOLFIRINOX, Pentamidine 300 MG Injection - Pancreatic Ductal Adenocarcinoma (PDAC) | Phase 1 | Not yet recruiting | University of Oklahoma | 30 | 2026-12-01 | 2026-09-18 |
| Symptom Trajectory Approaches to Research Health surveys - Advanced Cancer, Metastatic Disease | Not yet recruiting | University of Wisconsin, Madison | 228 | 2026-12-01 | 2026-09-04 |
Showing 20 of 4794. Sign in to see all of them.
Neoplasm Metastasis (3584) · Neoplasms (729) · Breast Neoplasms (709) · Colorectal Neoplasms (494) · Carcinoma, Non-Small-Cell Lung (404) · Recurrence (364) · Blast Crisis (356) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (332) · Leukemia, Myeloid, Acute (320) · Prostatic Neoplasms (306) · Melanoma (303) · Lung Neoplasms (292) · Neoplasm, Residual (283) · Pancreatic Neoplasms (263) · Leukemia, Myeloid, Accelerated Phase (245)
Pathological Conditions, Signs and Symptoms (4792) · Pathologic Processes (4780) · Neoplasms (4065) · Neoplasms by Site (3081) · Neoplasms by Histologic Type (1690) · Digestive System Diseases (1121) · Digestive System Neoplasms (1089) · Skin and Connective Tissue Diseases (1011) · Skin Diseases (1005) · Neoplasms, Glandular and Epithelial (874) · Urogenital Diseases (846) · Gastrointestinal Diseases (817) · Urogenital Neoplasms (802) · Gastrointestinal Neoplasms (757)
pembrolizumab (172) · Cyclophosphamide (163) · Gemcitabine (161) · Paclitaxel (140) · Capecitabine (135) · Fluorouracil (126) · Carboplatin (122) · Oxaliplatin (119) · Bevacizumab (118) · Cisplatin (110) · Docetaxel (109) · Leucovorin (108) · Nivolumab (103) · Radiotherapy (100) · Irinotecan (98)
M.D. Anderson Cancer Center (176) · National Cancer Institute (NCI) (175) · Memorial Sloan Kettering Cancer Center (74) · Eli Lilly and Company (73) · Novartis Pharmaceuticals (54) · AstraZeneca (53) · Fred Hutchinson Cancer Center (50) · Fudan University (41) · Pfizer (41) · H. Lee Moffitt Cancer Center and Research Institute (39) · University Health Network, Toronto (36) · Amgen (32) · City of Hope Medical Center (30) · Dana-Farber Cancer Institute (26) · UNC Lineberger Comprehensive Cancer Center (26)
United States (2482) · France (589) · China (577) · Spain (434) · Italy (376) · Canada (374) · Germany (357) · United Kingdom (336) · South Korea (285) · Belgium (272) · Australia (270) · Netherlands (251) · Taiwan (194) · Poland (172) · Japan (161)
PMID 36897458, PMID 33270906, PMID 37146227, PMID 37597578, PMID 28445469, PMID 32499241, PMID 34213592, PMID 38598571, PMID 38979716, PMID 41671463, PMID 12094370, PMID 14645423, PMID 15855973, PMID 17686822, PMID 18316791, PMID 18494054, PMID 19141862, PMID 20718753, PMID 21420083, PMID 21715313, PMID 21826194, PMID 22067397, PMID 22248721, PMID 22442346, PMID 22895629, PMID 23433878, PMID 23522151, PMID 23599758, PMID 24578254, PMID 24722180, PMID 24844673, PMID 24892406, PMID 24919854, PMID 25077927, PMID 25100135, PMID 25303679, PMID 25439688, PMID 25651787, PMID 25789053, PMID 26049686, PMID 26311728, PMID 26341722, PMID 26768165, PMID 27209293, PMID 27621408, PMID 28898379, PMID 29093181, PMID 29358182, PMID 30274985, PMID 30679026
2023 (59), 2019 (33), 2025 (30), 2017 (26), 2016 (25), P30CA016672 (24), P30CA033572 (22), 2014 (20), 2015 (20), P30CA043703 (20), 2018 (18), 2008 (17), P30CA015704 (14), UM1CA186709 (14), P30CA072720 (11)